This suggests that heterozygous SLC4A11 mutations in parents of individuals affected with CHED may be sufficient to cause FECD4 and thus it follows that a higher incidence of FECD would be observed in regions where CHED is more prevalent. The gene discussed is SLC4A11; the disease is congenital hereditary endothelial dystrophy of cornea.